Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma
2018 · Journal of Thoracic Oncology · 123 citations
https://doi.org/10.1016/j.jtho.2018.10.001
J
James B. Smadbeck
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
155
Papers
2.2K
Citations
26
h-index
50
i10-index
James B. Smadbeck is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Multiple Myeloma Research and Treatments & Acute Myeloid Leukemia Research. The author has an h-index of 26, co-authored 132 publications.
ORCID: 0000-0002-8902-0950Papers by this author
worksMate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma
2019 · Blood Cancer Journal · 36 citations
https://doi.org/10.1038/s41408-019-0255-z
Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine
2020 · JHEP Reports · 28 citations
https://doi.org/10.1016/j.jhepr.2020.100068
Tumor Junction Burden and Antigen Presentation as Predictors of Survival in Mesothelioma Treated With Immune Checkpoint Inhibitors
2021 · Journal of Thoracic Oncology · 24 citations
https://doi.org/10.1016/j.jtho.2021.10.022
Derivation of ligands for the complement C3a receptor from the C-terminus of C5a
2014 · European Journal of Pharmacology · 20 citations
https://doi.org/10.1016/j.ejphar.2014.10.041
Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2+ breast cancer samples
2018 · BMC Cancer · 20 citations
https://doi.org/10.1186/s12885-018-4594-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat